SG10201403109VA - Vaccine therapy for choroidal neovascularization - Google Patents
Vaccine therapy for choroidal neovascularizationInfo
- Publication number
- SG10201403109VA SG10201403109VA SG10201403109VA SG10201403109VA SG10201403109VA SG 10201403109V A SG10201403109V A SG 10201403109VA SG 10201403109V A SG10201403109V A SG 10201403109VA SG 10201403109V A SG10201403109V A SG 10201403109VA SG 10201403109V A SG10201403109V A SG 10201403109VA
- Authority
- SG
- Singapore
- Prior art keywords
- choroidal neovascularization
- vaccine therapy
- vaccine
- therapy
- choroidal
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60N—SEATS SPECIALLY ADAPTED FOR VEHICLES; VEHICLE PASSENGER ACCOMMODATION NOT OTHERWISE PROVIDED FOR
- B60N2/00—Seats specially adapted for vehicles; Arrangement or mounting of seats in vehicles
- B60N2/02—Seats specially adapted for vehicles; Arrangement or mounting of seats in vehicles the seat or part thereof being movable, e.g. adjustable
- B60N2/22—Seats specially adapted for vehicles; Arrangement or mounting of seats in vehicles the seat or part thereof being movable, e.g. adjustable the back-rest being adjustable
- B60N2/225—Seats specially adapted for vehicles; Arrangement or mounting of seats in vehicles the seat or part thereof being movable, e.g. adjustable the back-rest being adjustable by cycloidal or planetary mechanisms
- B60N2/2252—Seats specially adapted for vehicles; Arrangement or mounting of seats in vehicles the seat or part thereof being movable, e.g. adjustable the back-rest being adjustable by cycloidal or planetary mechanisms in which the central axis of the gearing lies inside the periphery of an orbital gear, e.g. one gear without sun gear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Transportation (AREA)
- Aviation & Aerospace Engineering (AREA)
- Mechanical Engineering (AREA)
- Microbiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Mycology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009140363 | 2009-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201403109VA true SG10201403109VA (en) | 2014-10-30 |
Family
ID=43308696
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201403109VA SG10201403109VA (en) | 2009-06-11 | 2010-06-10 | Vaccine therapy for choroidal neovascularization |
SG2011090933A SG176737A1 (en) | 2009-06-11 | 2010-06-10 | Vaccine therapy for choroidal neovascularization |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011090933A SG176737A1 (en) | 2009-06-11 | 2010-06-10 | Vaccine therapy for choroidal neovascularization |
Country Status (14)
Country | Link |
---|---|
US (1) | US8975229B2 (ja) |
EP (1) | EP2440226A4 (ja) |
JP (1) | JP5688587B2 (ja) |
KR (1) | KR20120038419A (ja) |
CN (1) | CN102802654A (ja) |
AU (1) | AU2010259797B2 (ja) |
BR (1) | BRPI1013025A2 (ja) |
CA (1) | CA2764562A1 (ja) |
IL (1) | IL216402A0 (ja) |
MX (1) | MX2011012659A (ja) |
RU (1) | RU2555345C2 (ja) |
SG (2) | SG10201403109VA (ja) |
TW (1) | TW201109029A (ja) |
WO (1) | WO2010143435A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2385396T3 (es) | 2005-02-28 | 2012-07-24 | Oncotherapy Science, Inc. | Péptidos epítopos derivados del receptor 1 del factor de crecimiento endotelial vascular y vacunas que contienen estos péptidos |
CA2678432A1 (en) * | 2007-02-16 | 2008-08-21 | Oncotherapy Science, Inc. | Vaccine therapy for choroidal neovascularization |
FR2990352A1 (fr) | 2012-05-10 | 2013-11-15 | Univ Paris 13 | Composition immunogene comprenant un peptide derive du vegf et ses utilisations |
JP7168228B2 (ja) * | 2017-05-19 | 2022-11-09 | 慶應義塾 | 脳神経疾患に対するペプチドワクチン及びペプチドワクチン組成物 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5861301A (en) | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
CN1701814A (zh) | 1992-11-13 | 2005-11-30 | 马克斯普朗克科学促进协会 | 作为血管内皮生长因子受体的f1k-1 |
JP3734262B2 (ja) | 1993-03-25 | 2006-01-11 | メルク エンド カンパニー インコーポレーテッド | 血管内皮細胞増殖因子阻害剤 |
US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
US6080728A (en) | 1996-07-16 | 2000-06-27 | Mixson; A. James | Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
DE19638745C2 (de) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) |
WO1998031794A1 (fr) | 1997-01-17 | 1998-07-23 | Toa Gosei Co., Ltd. | Polypeptide liant le facteur vegf |
ATE371727T1 (de) | 1997-06-18 | 2007-09-15 | Merck & Co Inc | Kdr, ein menschlicher tyrosin kinase rezeptor |
AU2299099A (en) | 1998-02-04 | 1999-08-23 | Kyowa Hakko Kogyo Co. Ltd. | Antibodies against human vegf receptor kdr |
GB9804121D0 (en) | 1998-02-26 | 1998-04-22 | Cancer Res Campaign Tech | Anti-angiogenic vaccines: materials and methods relating thereto |
AU3850299A (en) | 1998-05-20 | 1999-12-06 | Kyowa Hakko Kogyo Co. Ltd. | Vegf activity inhibitors |
WO2001012809A2 (en) | 1999-08-13 | 2001-02-22 | Crucell Holland B.V. | Heterodimeric vegf variants used for inhibiting angiogenesis |
US7264810B2 (en) | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
AU2002362461A1 (en) | 2001-10-01 | 2003-04-14 | Targesome, Inc. | Targeted therapeutic lipid constructs having cell surface targets |
CU23178A1 (es) * | 2002-04-15 | 2006-09-22 | Ct Ingenieria Genetica Biotech | INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA |
EP2267022B1 (en) | 2002-09-12 | 2015-02-11 | Oncotherapy Science, Inc. | KDR peptides and vaccines comprising the same |
AU2003272471B2 (en) | 2002-09-18 | 2010-10-07 | Trustees Of The University Of Pennsylvania | Method of inhibiting choroidal neovascularization |
CN1926551B (zh) | 2003-10-27 | 2010-06-16 | 罗斯塔生化科技有限责任公司 | 用于基因沉默的siRNA的设计方法 |
JP2006215988A (ja) * | 2005-02-07 | 2006-08-17 | Ntt Docomo Kansai Inc | 認証システム、携帯端末装置及び認証方法 |
ES2385396T3 (es) * | 2005-02-28 | 2012-07-24 | Oncotherapy Science, Inc. | Péptidos epítopos derivados del receptor 1 del factor de crecimiento endotelial vascular y vacunas que contienen estos péptidos |
US20060234941A1 (en) * | 2005-04-15 | 2006-10-19 | The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
JP2006315988A (ja) | 2005-05-11 | 2006-11-24 | Mototake Shimizu | ケモカイン産生誘導効果を有する血管新生阻害物質 |
CA2678432A1 (en) * | 2007-02-16 | 2008-08-21 | Oncotherapy Science, Inc. | Vaccine therapy for choroidal neovascularization |
EP2171082B1 (en) | 2007-06-14 | 2012-11-28 | Oncotherapy Science, Inc. | Methods of identifying agents that modulate methylation of vegfr1 by smyd3 |
TWI436775B (zh) | 2007-08-24 | 2014-05-11 | Oncotherapy Science Inc | 以抗原胜肽合併化療藥劑治療胰臟癌 |
-
2010
- 2010-06-08 TW TW099118513A patent/TW201109029A/zh unknown
- 2010-06-10 EP EP10785967.0A patent/EP2440226A4/en not_active Withdrawn
- 2010-06-10 BR BRPI1013025A patent/BRPI1013025A2/pt not_active IP Right Cessation
- 2010-06-10 SG SG10201403109VA patent/SG10201403109VA/en unknown
- 2010-06-10 JP JP2011552249A patent/JP5688587B2/ja not_active Expired - Fee Related
- 2010-06-10 AU AU2010259797A patent/AU2010259797B2/en not_active Expired - Fee Related
- 2010-06-10 CA CA2764562A patent/CA2764562A1/en not_active Abandoned
- 2010-06-10 KR KR1020117031702A patent/KR20120038419A/ko active Search and Examination
- 2010-06-10 CN CN2010800356548A patent/CN102802654A/zh active Pending
- 2010-06-10 MX MX2011012659A patent/MX2011012659A/es active IP Right Grant
- 2010-06-10 WO PCT/JP2010/003871 patent/WO2010143435A1/en active Application Filing
- 2010-06-10 RU RU2012100241/15A patent/RU2555345C2/ru not_active IP Right Cessation
- 2010-06-10 SG SG2011090933A patent/SG176737A1/en unknown
- 2010-06-10 US US13/377,110 patent/US8975229B2/en not_active Expired - Fee Related
-
2011
- 2011-11-17 IL IL216402A patent/IL216402A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102802654A (zh) | 2012-11-28 |
RU2012100241A (ru) | 2013-07-20 |
KR20120038419A (ko) | 2012-04-23 |
JP2012529423A (ja) | 2012-11-22 |
TW201109029A (en) | 2011-03-16 |
BRPI1013025A2 (pt) | 2016-04-05 |
EP2440226A1 (en) | 2012-04-18 |
WO2010143435A1 (en) | 2010-12-16 |
US8975229B2 (en) | 2015-03-10 |
MX2011012659A (es) | 2011-12-16 |
US20120156233A1 (en) | 2012-06-21 |
AU2010259797B2 (en) | 2015-06-25 |
SG176737A1 (en) | 2012-01-30 |
JP5688587B2 (ja) | 2015-03-25 |
AU2010259797A1 (en) | 2011-12-08 |
CA2764562A1 (en) | 2010-12-16 |
EP2440226A4 (en) | 2013-09-18 |
IL216402A0 (en) | 2012-01-31 |
RU2555345C2 (ru) | 2015-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL217008A0 (en) | Vaccine | |
EP2752198A4 (en) | PREPARATION OF VACCINE FOR THE TREATMENT OF CANCER | |
EP2740420A4 (en) | THERAPEUTIC TOOL | |
PL2444103T3 (pl) | Szczepionka przeciwko rakowi szyjki macicy | |
EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
GB201006165D0 (en) | Vaccine | |
EP2461850A4 (en) | DIRECTORATE OF THERAPEUTIC AGENTS | |
IL216102A0 (en) | Combined measles-malaria vaccine | |
EP2522360A4 (en) | VACCINE FOR TAUTOPATHY TREATMENT | |
IL216402A0 (en) | Vaccine therapy for choroidal neovascularization | |
GB2467215B (en) | Burkholderia components vaccine | |
ZA201402071B (en) | Vaccine therapy | |
EP2688566A4 (en) | ANTICANCER THERAPEUTIC AGENTS | |
HRP20180744T1 (hr) | Terapeutska cjepiva | |
HK1134449A1 (en) | Vaccine therapy for choroidal neovascularization | |
IL217194A0 (en) | Vaccine | |
GB201010500D0 (en) | Therapeutic conjugates | |
ZA201205056B (en) | Therapeutic use of protein-polymer conjugates | |
GB0801424D0 (en) | Therapeutic vaccines | |
GB0802405D0 (en) | Therapeutic vaccines | |
GB0919114D0 (en) | Therapeutic intervention | |
ZA201107971B (en) | Combined measles-malaria vaccine | |
GB0914545D0 (en) | Vaccine |